OLMA holder plans sale of 10,000 shares

OLMA received a Form 144 notice indicating an intent to sell up to 10,000 shares of its common stock through Fidelity Brokerage Services LLC on or about 01/12/2026 on the NASDAQ market, with an aggregate market value of $283,362.96 at the time of the notice.

Accepted by SEC EDGAR 01/12/2026 - 12:53 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

OLMA received a Form 144 notice indicating an intent to sell up to 10,000 shares of its common stock through Fidelity Brokerage Services LLC on or about 01/12/2026 on the NASDAQ market, with an aggregate market value of $283,362.96 at the time of the notice. These 10,000 shares were originally acquired on 06/30/2014 from the issuer via a convertible note transaction paid in cash. The notice also reports that security holder David C. Myles sold 51,000 common shares on 12/19/2025 for gross proceeds of $1,553,447.42. By signing, the seller represents that they are not aware of undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OLMA Form 144 filing disclose?

The Form 144 discloses an intended sale of up to 10,000 shares of OLMA common stock on or about 01/12/2026 on the NASDAQ market through Fidelity Brokerage Services LLC, with an aggregate market value of $283,362.96 at the time of the notice.

Who is selling OLMA shares and how many were recently sold?

The notice identifies David C. Myles as a seller who, during the past three months, sold 51,000 OLMA common shares on 12/19/2025 for gross proceeds of $1,553,447.42, and now intends to sell an additional 10,000 shares.

How and when were the OLMA shares to be sold originally acquired?

The 10,000 OLMA common shares covered by the Form 144 were acquired on 06/30/2014 from the issuer via a convertible note transaction, with payment made in cash on the same date.

How many OLMA shares are outstanding as referenced in the Form 144?

The Form 144 indicates that there were 68,659,923 OLMA common shares outstanding, providing context for the size of the planned 10,000-share sale.

What representation does the seller make in the OLMA Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the current or prospective operations of the issuer that has not been publicly disclosed.

Which broker will handle the planned OLMA share sale?

The planned sale of up to 10,000 OLMA common shares is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001831216
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Olema Pharmaceuticals, Inc.
SEC File Number	001-39712
Address of Issuer	780 BRANNAN STREET SAN FRANCISCO CALIFORNIA 94103
Phone	(415) 651-3316
Name of Person for Whose Account the Securities are To Be Sold	Myles David C.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	283362.96	68659923	01/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2014	Convertible Note	Issuer			10000	06/30/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David C. Myles 780 Brannan Street San Francisco CA 94103	Common	12/19/2025	51000	1553447.42

144: Remarks and Signature

Remarks	Today's sale occurred in the corporate account of Myles Properties, Inc, of which David C. Myles is an authorized individual and an account stakeholder.
Date of Notice	01/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David C. Myles
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)